All In Biotech

Drug Trial Radar · NCT06960213

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

STOP-HAE: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of siRNA Targeting of Prekallikrein With ADX-324 in Participants With Hereditary Angioedema

Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Aug 28, 2025

Primary completion

Nov 30, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
ADARx Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
May 7, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema. The study will also evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD), and health-related quality of life measures.

Conditions

  • Hereditary Angioedema
  • HAE
  • Hereditary Angioedema - Type 1
  • Hereditary Angioedema - Type 2

Interventions

  • ADX-324Drug

    siRNA duplex oligonucleotide

  • PlaceboDrug

    saline

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of ADX-324 in preventing HAE attacksTime frame: Day 22 to Week 25

Locations

70 sites in 24 countries. Site status is shown where the registry gives one.

  • ADARx Clinical Site

    Litchfield Park, Arizona · Recruiting

  • ADARx Clinical Site

    Scottsdale, Arizona · Recruiting

  • ADARx Clinical Site

    Little Rock, Arkansas · Recruiting

  • ADARx Clinical Site

    San Diego, California · Recruiting

  • ADARx Clinical Site

    Santa Monica, California · Not yet recruiting

  • ADARx Clinical Site

    Walnut Creek, California · Recruiting

  • ADARx Clinical Site

    Centennial, Colorado · Recruiting

  • ADARx Clinical Site

    Orlando, Florida · Recruiting

  • ADARx Clinical Site

    Chevy Chase, Maryland · Recruiting

  • ADARx Clinical Site

    Wheaton, Maryland · Withdrawn

  • ADARx Clinical Site

    Detroit, Michigan · Recruiting

  • ADARx Clinical Site

    St Louis, Missouri · Recruiting

  • ADARx Clinical Site

    Las Vegas, Nevada · Recruiting

  • ADARx Clinical Site

    New York, New York · Recruiting

  • ADARx Clinical Site

    Cincinnati, Ohio · Recruiting

  • ADARx Clinical Site

    Cleveland, Ohio · Not yet recruiting

  • ADARx Clinical Site

    Columbus, Ohio · Withdrawn

  • ADARx Clinical Site

    Toledo, Ohio · Recruiting

  • ADARx Clinical Site

    Hershey, Pennsylvania · Recruiting

  • ADARx Clinical Site

    Pilar, Argentina · Recruiting

  • ADARx Clinical Site

    Rosario, Argentina · Recruiting

  • ADARx Clinical Site

    Capital Federal, Buenos Aires, Argentina · Recruiting

  • ADARx Clinical Site

    Buenos Aires, Buenos Aires F.D., Argentina · Recruiting

  • ADARx Clinical Site

    Campbelltown, New South Wales, Australia · Not yet recruiting

  • ADARx Clinical Site

    Adelaide, South Australia, Australia · Recruiting

  • ADARx Clinical Site

    Vienna, Austria · Recruiting

  • ADARx Clinical Site

    Edegem, Antwerpen, Belgium · Recruiting

  • ADARx Clinical Site

    Campinas, Brazil · Not yet recruiting

  • ADARx Clinical Site

    São Paulo, Brazil · Not yet recruiting

  • ADARx Clinical Site

    Sofia, Bulgaria · Recruiting

  • ADARx Clinical Site

    Edmonton, Alberta, Canada · Withdrawn

  • ADARx Clinical Site

    Edmonton, Alberta, Canada · Not yet recruiting

  • ADARx Clinical Site

    Ottawa, Ontario, Canada · Withdrawn

  • ADARx Clinical Site

    Montreal, Quebec, Canada · Recruiting

  • ADARx Clinical Site

    Beijing, China · Recruiting

  • ADARx Clinical Site

    Harbin, China · Not yet recruiting

  • ADARx Clinical Site

    Zhengzhou, China · Not yet recruiting

  • ADARx Clinical Site

    Split, Croatia · Recruiting

  • ADARx Clinical Site

    Zagreb, Croatia · Recruiting

  • ADARx Clinical Site

    Hradec Králové, Czechia · Recruiting

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.